BridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives $40.23 Average PT from Analysts
Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the thirteen ratings firms that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and twelve have issued a buy recommendation on the company. The average […]
More Stories
Financial Contrast: Carnival Co. & (NYSE:CUK) versus Viking (NYSE:VIK)
Viking (NYSE:VIK – Get Free Report) and Carnival Co. & (NYSE:CUK – Get Free Report) are both transportation companies, but...
Centaurus Financial Inc. Lowers Stock Holdings in iShares Core S&P Mid-Cap ETF (NYSEARCA:IJH)
Centaurus Financial Inc. cut its stake in shares of iShares Core S&P Mid-Cap ETF (NYSEARCA:IJH – Free Report) by 2.5%...
PepsiCo, Inc. (NASDAQ:PEP) Shares Purchased by Summit Trail Advisors LLC
Summit Trail Advisors LLC increased its position in shares of PepsiCo, Inc. (NASDAQ:PEP – Free Report) by 18.3% during the...
Costco Wholesale Co. (NASDAQ:COST) Shares Acquired by Daiwa Securities Group Inc.
Daiwa Securities Group Inc. boosted its stake in Costco Wholesale Co. (NASDAQ:COST – Free Report) by 19.0% in the third...
SevenBridge Financial Group LLC Buys 335 Shares of Chevron Co. (NYSE:CVX)
SevenBridge Financial Group LLC grew its stake in Chevron Co. (NYSE:CVX – Free Report) by 3.3% in the third quarter,...
Pekin Hardy Strauss Inc. Purchases 4,083 Shares of Chevron Co. (NYSE:CVX)
Pekin Hardy Strauss Inc. increased its holdings in shares of Chevron Co. (NYSE:CVX – Free Report) by 12.8% during the...